2,4-thiazolidinedione has been researched along with Retinal Neovascularization in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we demonstrated that GPU-4, 5-arylidene-2,4-thiazolidinedione derivative, demonstrates anti-angiogenic activity regarding human retinal microvascular endothelial cells (HRMECs) and retinal neovascularization in a mouse model of retinopathy of prematurity." | 3.77 | An arylidene-thiazolidinedione derivative, GPU-4, without PPARĪ³ activation, reduces retinal neovascularization. ( Hara, H; Hayashi, K; Kakuta, H; Murase, T; Nagasawa, H; Nakamura, S; Shimazawa, M; Takizawa, H; Tsuruma, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, S | 1 |
| Hayashi, K | 1 |
| Takizawa, H | 1 |
| Murase, T | 1 |
| Tsuruma, K | 1 |
| Shimazawa, M | 1 |
| Kakuta, H | 1 |
| Nagasawa, H | 1 |
| Hara, H | 1 |
1 other study available for 2,4-thiazolidinedione and Retinal Neovascularization
| Article | Year |
|---|---|
An arylidene-thiazolidinedione derivative, GPU-4, without PPARĪ³ activation, reduces retinal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Benzylidene Compounds; Cells, Cultured; Disease Models, Animal; En | 2011 |